Vanderbilt University and Bristol-Myers Squibb Sign Collaboration Agreement to Develop Novel Treatments for Parkinsonís Disease
(September 25, 2012) The Parkinson’s Unity Walk is proud to have supported this research, led by The Michael J. Fox Foundation and Vanderbilt University, toward a new class of symptomatic treatment for Parkinson’s disease. Read more about this “win for Parkinson’s patients” now advancing to the final stages of pre-clinical development with support from Bristol-Myers Squibb.
For additional information, read the official press release from Bristol-Myers Squibb.
A special thanks to all our supporters who make the Walk possible, because of your support, we are able to help fund this study. With continued help from Unity Walk supporters, we will be able to help fund more research projects like this one. Thank you for your continued support.